Robert Garver
Pulmonary Disease · Andalusia, ALNPI 1639113707
Payments from drug & device makers
Across 656 payments — averaging $6962.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1.8M
- Genentech, Inc.$1.2M
- AstraZeneca$393K
- Chiesi USA, Inc.$360K
- Boehringer Ingelheim$277K
- Hoffmann-la Roche Limited$250K
- plus $257K from 12 others
Across 32 payments — averaging $142.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$2K
- Sanofi Pasteur Inc.$1K
- Sanofi US Services Inc.$1K
What the payments were for
- Travel & lodging$6,46567%
- Food & beverage$3,23533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 48 | $1,805,415 |
| Genentech, Inc. | 291 | $1,225,246 |
| AstraZeneca | 26 | $392,978 |
| Chiesi USA, Inc. | 74 | $359,794 |
| Boehringer Ingelheim | 31 | $276,586 |
| Hoffmann-la Roche Limited | 32 | $249,867 |
| Verona Pharma, Inc. | 11 | $148,285 |
| Sanofi US Services Inc. | 11 | $45,276 |
| GSK | 32 | $38,201 |
| Boehringer Ingelheim International GmbH | 45 | $13,976 |
| Novo Nordisk AS | 1 | $3,195 |
| Astrazeneca UK Limited | 14 | $2,057 |
| Eli Lilly | 19 | $1,904 |
| Mylan Specialty L.p. | 1 | $1,500 |
| Bayer | 9 | $1,430 |
| Modernatx, Inc. | 4 | $1,346 |
| Sunovion Pharmaceuticals Inc. | 5 | $57 |
| Grifols USA, LLC | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QBW251$665
How this compares
$4,567,147 in reported general payments places this provider in the 95th percentile of 215 pulmonary disease providers in Alabama.
Other pulmonary disease in Andalusia
- Allan SeibertMobile$2.4M
- Tejaswini KulkarniBirmingham$1.7M
- Jan WestermanJasper$834K
- Bryan GarciaBirmingham$606K
- A RidgewaySheffield$434K
- Darryle BullardCullman$380K
- Marvin SextonDothan$346K
- Veena AntonyBirmingham$327K
- William SaliskiMontgomery$257K
- Steven RoweBirmingham$252K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.